These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11908682)

  • 21. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
    Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
    Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
    Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
    Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic vessel activation in cancer.
    Das S; Skobe M
    Ann N Y Acad Sci; 2008; 1131():235-41. PubMed ID: 18519976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of lymphangiogenesis--from cell fate determination to vessel remodeling.
    Karpanen T; Mäkinen T
    Exp Cell Res; 2006 Mar; 312(5):575-83. PubMed ID: 16343484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis and lymphangiogenesis of skin cancers.
    Dadras SS; Detmar M
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1059-70, viii. PubMed ID: 15474335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.
    de la Torre NG; Buley I; Wass JA; Turner HE
    Endocr Relat Cancer; 2006 Sep; 13(3):931-44. PubMed ID: 16954441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival.
    Schoppmann SF; Fenzl A; Nagy K; Unger S; Bayer G; Geleff S; Gnant M; Horvat R; Jakesz R; Birner P
    Surgery; 2006 Jun; 139(6):839-46. PubMed ID: 16782443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphangiogenesis and its role in cancer.
    Al-Rawi MA; Mansel RE; Jiang WG
    Histol Histopathol; 2005 Jan; 20(1):283-98. PubMed ID: 15578446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review).
    Schoppmann SF; Horvat R; Birner P
    Oncol Rep; 2002; 9(3):455-60. PubMed ID: 11956609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the lymphatics in cancer metastasis and chemotherapy applications.
    McAllaster JD; Cohen MS
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):867-75. PubMed ID: 21699937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal lymphangiogenesis: implications in immunity.
    Patel SP; Dana R
    Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer lymphangiogenesis and its role in metastasic dissemination].
    Utrera-Barillas MD; Castro-Manrreza ME; Gutiérrez-Rodríguez M; Benítez-Bribiesca L
    Gac Med Mex; 2009; 145(1):51-60. PubMed ID: 19256411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of immune system in colon metastasis. Lymphangiogenesis or lymphedema in cancer tissue].
    Stańczyk M; Olszewski WL; Gewartowska M; Maruszyński M
    Pol Merkur Lekarski; 2007 May; 22(131):457-9. PubMed ID: 17679395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium.
    Irjala H; Alanen K; Grénman R; Heikkilä P; Joensuu H; Jalkanen S
    Cancer Res; 2003 Aug; 63(15):4671-6. PubMed ID: 12907648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
    Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG
    Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
    Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
    Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.